FDA Import Refusal AEK-7261205-2/12/1 — Boehringer Ingelheim Pharma GmbH & Co. KG
The FDA refused shipment AEK-7261205-2/12/1 from Boehringer Ingelheim Pharma GmbH & Co. KG (Germany) on July 23, 2025. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- July 23, 2025
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 61PAA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 118,75